Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer - Quiz - MDSpire

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer

  • By

  • Alberto Farolfi

  • Chiara Casadei

  • Emanuela Scarpi

  • Eleonora Paoletti

  • Caterina Gianni

  • Michela Palleschi

  • Nicola Gentili

  • Marita Mariotti

  • Sara Testoni

  • Giandomenico Di Menna

  • Francesca Rusconi

  • Alice Andalò

  • Olga Serra

  • Filippo Merloni

  • Marianna Sirico

  • Roberta Maltoni

  • Lorenzo Cecconetto

  • Samanta Sarti

  • Antonino Musolino

  • July 14, 2026

Share

Original Source(s)

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer

  • by Alberto Farolfi, Chiara Casadei, Emanuela Scarpi, Eleonora Paoletti, Caterina Gianni, Michela Palleschi, Nicola Gentili, Marita Mariotti, Sara Testoni, Giandomenico Di Menna, Francesca Rusconi, Alice Andalò, Olga Serra, Filippo Merloni, Marianna Sirico, Roberta Maltoni, Lorenzo Cecconetto, Samanta Sarti, Antonino Musolino

  • July 14, 2026

Related Content

Interpretable machine learning-driven multi-omics risk stratification and drug repurposing nominates Treg/Th17 with gluconeogenesis/lactylation integration as a prognostic and druggable biomarker for glioblastoma patients

Multimodal imaging diagnosis of multiple myeloma with renal involvement: a case report

Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk